Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ned Tijdschr Geneeskd ; 1642020 04 02.
Article in Dutch | MEDLINE | ID: mdl-32392014

ABSTRACT

Hydroxycarbamide is a cytotoxic drug that is used in haematological cancers. On long-term use (2-15 years) of 1500-2000 mg a day, there is a 9% risk of developing ulcers. This patient's ulcer was painful, of punched out aspect, with a necrotic base and swollen wound edges. Upon discontinuation of hydroxycarbamide, the wound healed within 2 months.


Subject(s)
Ankle/pathology , Hematologic Neoplasms/drug therapy , Hydroxyurea , Skin Diseases , Ulcer , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Humans , Hydroxyurea/administration & dosage , Hydroxyurea/adverse effects , Long Term Adverse Effects/chemically induced , Long Term Adverse Effects/therapy , Male , Pain/diagnosis , Pain/etiology , Skin Diseases/chemically induced , Skin Diseases/physiopathology , Skin Diseases/therapy , Treatment Outcome , Ulcer/chemically induced , Ulcer/physiopathology , Ulcer/therapy , Withholding Treatment
SELECTION OF CITATIONS
SEARCH DETAIL
...